Monday, May 27, 2019 3:14:39 AM
"We expect to have two distribution contracts
before the end of the first quarter of 2019.
One distribution contract for Grupo Nutresa
and one distribution contract
for Ingredion Colombia SA"
Kate Bahnsen, CEO
https://www.incaworldwide.com/blog/author/Kate--Bahnsen
_______________________________________________________________
-----------------------------------------------------------------
January 31, 2019
Two Distribution Contracts
expected by end of first Quarter of 2019
Ingredion Colombia SA
moves forward with Sacha Inchi Powder
to add to their current products
https://www.ingredion.co/
https://translate.google.com/translate?hl=en&sl=es&u=https://www.ingredion.co/&prev=search
Ingredion Colombia SA
met with the CEO of Inca Worldwide (OTC-QEDN)
in December 2018 to discuss the possibility
of adding Sacha Inchi Powder
to the current products.
After the meeting,
both companies signed an NDA.
Ingredion Colombia SA
sent the Sacha Inchi Powder samples for analysis
and now we have started the second phase
of product development.
Ingredion Colombia SA
produces formulas
for children, pregnant women
and people over 62.
These formulas are sold
to different Colombian government programs.
GMS and Ingredion Colombia SA
will continue to work together
to develop formulas that can be provided
to farmers that grow Sacha Inchi
at a low cost.
This way our farmers can benefit
from the Sacha Inchi they grow.
We expect to have two Distribution Contracts
before the end of the first quarter of 2019.
One Distribution Contract for Grupo Nutresa
and one Distribution Contract
for Ingredion Colombia SA
https://twitter.com/IncaSnacks/status/1090927728545722368
https://www.incaworldwide.com/single-post/2019/01/31/Ingredion-Colombia-SA-moves-forward-with-Sacha-Inchi-Powder-to-add-to-their-current-products
_________________________________________________________________
January 30, 2019
QEDN - Product development with Nutresa
https://www.gruponutresa.com/
https://translate.google.com/translate?hl=en&sl=es&u=https://www.gruponutresa.com/&prev=search
Nutresa
moves to product development stage
with GMS and Inca Worldwide
Kate Bahnsen the CEO of Inca Worldwide (OTC:QEDN)
and GMS met yesterday January 30, 2019
in Nutresa with the director of product development
of Noel S.A., the director of Fundacion Nutresa,
the head of purchasing department of Grupo Nutresa
and the director of sustainable products.
During that meeting,
it was agreed to start working with Noel
to add Sacha Inchi Powder
to their current products.
It was also discussed if el Grupo Nutresa
could packet Sacha Inchi for their own products,
for GMS and for customers that want to have
their own Sacha Inchi brand products.
After this product development is done
we discuss that
GMS will get a letter of interest
and then suppliers agreement contract
from Grupo Nutresa.
Grupo Nutresa,
formerly Grupo Nacional de Chocolates S.A.
is a food-processing conglomerate
headquartered in Medellín, Colombia.
The group's principal activities are
producing, distributing,
and selling cold cuts, biscuits,
chocolates, coffee, ice cream, and pasta
https://twitter.com/IncaSnacks/status/1090571370143145986
https://www.incaworldwide.com/single-post/2019/01/30/Nutresa-moves-to-product-development-stage-with-GMS-and-Inca-Worldwide
______________________________________________________________
Live! Charts
______________________________________________________________
Kate Bahnsen
CEO,
MBA Co-founder of Inca Seeds and Snacks
https://www.incaworldwide.com/our-story
https://twitter.com/IncaSnacks
https://www.incaworldwide.com/blog/author/Kate--Bahnsen
10 Surprising Benefits of Sacha Inchi
https://www.youtube.com/watch?v=lDqRJESFtco
https://docs.wixstatic.com/ugd/accfca_7139ac0f0be045c5af2e6901d01cc4f0.pdf
________________________________________________________________
________________________________________________________________
________________________________________________________________
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
________________________________________________________________
_______________________________________________________________
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM